FERMENTA BIOTECH LIMITED — Board/Management Information 2024

Nov 14, 2024

==> picture [482 x 78] intentionally omitted <==

F. No.: 908

November 14, 2024

Corporate Relations BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai – 400 001

Dear Sir,

Sub: Outcome of Board Meeting held on November 14, 2024 pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR')

Ref: Scrip Code 506414

We write to inform you that the Board of Directors of the Company at its meeting held on November 14, 2024, has, inter alia, approved the following:

(a) Appointment of Mr. Ramanand Mundkur as an Additional (Independent) Director:

The Board approved an appointment of Mr. Ramanand Mundkur (DIN: 03498212) as an Additional Director, in the capacity of Independent Director, with effect from November 14, 2024. His appointment as an Independent Director of the Company for the first term shall be for a period of 3 (three) consecutive years with effect from November 14, 2024, subject to approval of the members of the Company.

(b) Re-appointment of Ms. Rajashri Ojha as an Independent Director:

The Board approved re-appointment of Ms. Rajashri Ojha (DIN: 07058128) as an Independent Director for a second term for a period of 3 (three) consecutive years with effect from April 1, 2025, subject to approval of the members of the Company.

The disclosure in relation to the aforesaid appointment and re-appointment, as required under SEBI Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024 is enclosed as Annexure 1.

(c) Postal Ballot:

The Board approved the postal ballot notice for seeking approval of the members of the Company for the aforesaid appointment of Mr. Ramanand Mundkur and re-appointment of

==> picture [491 x 68] intentionally omitted <==

==> picture [482 x 78] intentionally omitted <==

Ms. Rajashri Ojha as Independent Directors of the Company, by way of postal ballot including remote e-voting.

The Notice shall be sent to those members whose names appear in the Register of Members / List of Beneficial Owners, maintained by the Company / Depositories as on the cut-off date i.e. close of business hours on Friday, November 22, 2024.

The postal ballot notice and other requisite details will be intimated in due course.

Kindly take the above on record.

Thanking you,

Yours faithfully,

For Fermenta Biotech Limited

VARADVINAYA Digitally signed by VARADVINAYAK VIJAY K VIJAY KHAMBETE KHAMBETE Date: 2024.11.14 14:22:16 +05'30'

Varadvinayak Khambete

Company Secretary & Head - Legal Membership No. A33861

Encl: As above

==> picture [491 x 68] intentionally omitted <==

==> picture [482 x 78] intentionally omitted <==

Annexure 1

- Appointment/re appointment of Directors.

Sr. No.		Particulars	Mr. Ramanand Mundkur	Ms. Rajashri Ojha
1		Reason for change viz. appointment, resignation, removal, death or otherwise;	Appointment as an Additional Director in the capacity of Independent Director.	Re-appointment as an Independent Director.
2		Date of appointment/ re-appointment ~~/cessation~~ ~~(as~~ ~~applicable)~~& term of appointment/ re- appointment	November 14, 2024. Mr. Ramanand Mundkur shall hold his office as an Additional Director up to the date of the next general meeting in terms of Section 161 of the Companies Act, 2013 or for a period of three months from the date of appointment in terms of Regulation 17(1C) of LODR, whichever is earlier. Mr. Mundkur’s appointment as an Independent Director for a first term for a period of 3 (three) consecutive years with effect from November 14, 2024 is subject to the approval of the members of the Company.	April 1, 2025. Ms. Rajashri Ojha is an Independent Director on the Board of Directors of the Company, appointed w.e.f. April 01, 2020, and her first term as such would end on March 31, 2025. Ms. Rajashri Ojha’s re- appointment as an Independent Director for a second term for a period of 3 (three) years with effect from April 01, 2025 is subject to the approval of the members of the Company.
3		Brief profile (in case of appointment)	Mr. Ramanand Mundkur has around 30 years of experience. He holds B.A., LL.B. (Honors) degrees from National Law School, Bangalore, India and has completed Masters in Law from Harvard Law School, Cambridge, USA. He is qualified to practice law in the USA (New York State) and India. He has previously worked with the United Nations in Geneva, Switzerland, and International Monetary Fund in Washington DC for a number of years, and was also previously associated with Arthur Andersen & Co, in India. Mr. Mundkur has expertise in managing financial sector	Ms. Rajashri Ojha is an Independent Director on the Board of Directors of the Company. She has around 35 years of experience in pharmaceutical, nutraceutical, medical devices, cosmetics, and food and veterinary industries. She has expertise in various areas including global drug regulatory affairs, QC-QA-QM, regulatory compliance, audits and inspections, registration and marketing approvals across the globe, and providing guidance and training on regulatory aspects.

==> picture [491 x 68] intentionally omitted <==

==> picture [482 x 78] intentionally omitted <==

		issues, corporate governance, complex cross-border transactions, mergers and acquisitions, arbitration and international dispute resolution. He is also a law school visiting faculty.	She has received various awards over the years for her contribution in these areas including TOPRA-UK Award For Regulatory Excellence.
4	Disclosure of relationships between directors (in case of appointment of a director).	None	None

==> picture [491 x 68] intentionally omitted <==

---